Coldstream Capital Management Inc Adma Biologics, Inc. Call Options Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ADMA
# of Institutions
363Shares Held
188MCall Options Held
1.95MPut Options Held
646K-
Black Rock Inc. New York, NY18.6MShares$442 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.8MShares$399 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.9MShares$305 Million0.05% of portfolio
-
State Street Corp Boston, MA11.4MShares$271 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.67MShares$134 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $4.66B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...